Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Interaction of. gamma. -irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'-(acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:5275211
AZQ and AMSA were evaluated in combination with irradiation in murine tumor systems. In mice bearing ascitic P388 leukemia AZQ plus whole-body irradiation was slightly more effective in prolonging lifespan than maximally tolerated doses of either modality alone. Using an assay for cell survival, AZQ did not influence the response of P388 cells to radiation in vivo; the cytotoxicity of the two modalities was simply additive. AMSA, at a therapeutic dose administered prior to irradiation, did alter the response of P388 leukemia to irradiation with both a decrease in shoulder and an increase in slope. AMSA was also evaluated either prior to or after irradiation against B16 melanoma. AMSA alone had no influence on the growth of B16 melanoma. In combination with radiation AMSA pretreatment resulted in somewhat longer tumor growth delay than irradiation alone.
Research Organization:
Arthur D. Little, Inc., Cambridge, MA
OSTI ID:
5275211
Conference Information:
Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Journal Volume: 5:9
Country of Publication:
United States
Language:
English

Similar Records

Identification of the principal biliary metabolite of 4'-(9-acridinylamino)methanesulfon-m-anisidide in rats
Journal Article · · Drug Metab. Dispos.; (United States) · OSTI ID:6656163

Combined therapy with an aziridine derivative NSC 200724 (AB182) and radiation on an experimental leukemia
Conference · Sat Sep 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5339070

Therapeutic Efficacy of a {sup 188}Re-Labeled {alpha}-Melanocyte-Stimulating Hormone Peptide Analog in Murine and Human Melanoma-Bearing Mouse Models
Journal Article · Fri Dec 31 23:00:00 EST 2004 · Journal of Nuclear Medicine · OSTI ID:15011643